Profile
Anna Steeger is currently the Managing Director at Polyventures GmbH and the Managing Partner at 1717 Life Sciences Ventures GmbH.
She previously worked as an Independent Director at Eckert & Ziegler BEBIG SA and as a Co-Managing Director at PentixaPharm GmbH.
Anna Steeger active positions
| Companies | Position | Start |
|---|---|---|
1717 Life Sciences Ventures GmbH
1717 Life Sciences Ventures GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 2016-12-31 |
Polyventures GmbH | Chief Executive Officer | - |
Former positions of Anna Steeger
| Companies | Position | End |
|---|---|---|
PentixaPharm GmbH
PentixaPharm GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotech company that discovers and develops novel targeted radiopharmaceuticals | Chief Executive Officer | - |
| ECKERT & ZIEGLER BEBIG | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Eckert & Ziegler BEBIG SA
Eckert & Ziegler BEBIG SA Medical SpecialtiesHealth Technology Engages in the manufacturing of cancer, radiotherapy and brachytherapy products | Health Technology |
1717 Life Sciences Ventures GmbH
1717 Life Sciences Ventures GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Polyventures GmbH | |
PentixaPharm GmbH
PentixaPharm GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotech company that discovers and develops novel targeted radiopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Anna Steeger
















